STOCK TITAN

Elevance Health Inc Stock Price, News & Analysis

ELV NYSE

Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.

Elevance Health, Inc. (NYSE: ELV) generates a steady stream of news as a major participant in the direct health and medical insurance carriers industry. Company updates frequently focus on financial performance, member experience initiatives, digital tools, and community health programs. Investors and observers following ELV news can see how Elevance Health communicates its strategy as a lifetime, trusted health partner serving over 109 million consumers through medical, pharmacy, behavioral, clinical, home health, and complex care solutions.

News coverage often includes earnings results and guidance, such as quarterly financial releases that detail segment performance for Health Benefits and Carelon, membership trends across commercial, Medicare, Medicaid, and Federal Employee Program lines, and commentary on benefit expense ratios and operating metrics. The company also issues announcements about upcoming conference calls and webcasts where management reviews results and outlook with investors.

Another key theme in Elevance Health news is the evolution of the healthcare consumer experience. Articles describe AI-enabled digital solutions, including the Virtual Assistant available through the Sydney Health app, which helps members understand benefits, compare costs, and find in-network providers. The company also highlights care management programs, concierge-style support for serious illnesses, and models such as “My Health Advocate” in affiliated Medicare plans.

Elevance Health news frequently covers whole-health and community initiatives. Examples include Food as Medicine partnerships with the National Association of Community Health Centers, school-based fitness facility upgrades, and expanded access to doula care and social supports in certain Medicare Advantage and Medicaid plans. Governance developments, such as the appointment of independent directors to the board and related committee assignments, are also reported through press releases and SEC-linked announcements.

By reviewing the ELV news feed on this page, readers can follow financial disclosures, strategic initiatives, digital and clinical innovations, and community-focused programs that shape Elevance Health’s role in the health benefits and healthcare services landscape.

Rhea-AI Summary

Elevance Health (NYSE: ELV) has scheduled its fourth quarter and full year 2024 financial results announcement for January 23, 2025, at 6:00 a.m. EST. The company will host a conference call at 8:30 a.m. EST the same day to discuss the results and future outlook.

Participants can join the call using domestic (888-947-9963) or international (312-470-0178) numbers with access code 3972058. A replay will be available from 11:30 a.m. EST on January 23 until February 21, 2025. The event will also be accessible via live webcast on the company's website under the 'Investors' section.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
conferences earnings
-
Rhea-AI Summary

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and various credit ratings for Elevance Health Inc. (NYSE: ELV) and its subsidiaries. The outlook for all ratings remains stable. The affirmations reflect Anthem Health's very strong balance sheet, strong operating performance, and favorable business profile.

Key highlights include a 5-year compound annual capital growth rate of 8%, outpacing premium growth of 6.8%. The company maintains a conservative investment portfolio and sound liquidity with access to $4 billion in credit facilities. Financial leverage increased to 42% due to recent debt issuance but is expected to return to the 40% range by 2025.

Despite challenges in Medicaid membership due to state redeterminations, Elevance maintains strong profitability ratios and operates BCBS plans in 14 states with significant market presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
none
-
Rhea-AI Summary

Elevance Health (NYSE: ELV) has announced its senior management will present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California. The presentation is scheduled for November 12 at 7:15 a.m. PST (10:15 a.m. EST). A live webcast will be available on the company's website, with a replay accessible for 90 days following the presentation. Interested parties are advised to visit www.elevancehealth.com at least 15 minutes before the presentation to install necessary audio software.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.67%
Tags
none
Rhea-AI Summary

Elevance Health (NYSE: ELV) has appointed Nathan Rich as Vice President of Investor Relations, effective November 11, 2024. Rich will lead the company's investor relations efforts and join the executive leadership team, reporting to CFO Mark Kaye. He succeeds Stephen Tanal, who transitions to CFO of Elevance Health's Government Health Benefits business. Rich brings nearly two decades of experience, previously serving as VP in Global Investment Research at Goldman Sachs and as a sell-side research analyst at Citi.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
management
-
Rhea-AI Summary

Adam Herbst has joined Sheppard Mullin as a healthcare partner in New York, becoming the ninth healthcare partner to join in 2024. Previously serving as New York State Department of Health's Deputy Commissioner for Aging and Long Term Care, Herbst brings expertise in healthcare policy, Medicaid reform, and corporate governance. His experience includes overseeing regulation for New York's acute care, post-acute care, disability, and long-term care industries. The firm highlights its active long-term care practice, citing recent major transactions including a strategic partnership with Elevance Health and various joint ventures in the healthcare sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
none
-
Rhea-AI Summary

Elevance Health (NYSE: ELV) reported third quarter 2024 results with operating revenue of $44.7 billion, a $2.2 billion increase from the prior year. The company's adjusted operating gain was $2.4 billion, with diluted EPS of $4.36 and adjusted diluted EPS of $8.37. Elevance Health revised its 2024 outlook, now expecting GAAP net income per diluted share to be approximately $26.50 and adjusted net income per diluted share to be approximately $33.00.

The benefit expense ratio increased to 89.5%, up 270 basis points, primarily due to a timing mismatch between Medicaid rates and higher member acuity. The operating expense ratio improved to 11.8%, or 9.6% excluding adjustment items. The company's Health Benefits segment saw operating revenue increase to $38.3 billion, while Carelon's operating revenue grew to $13.8 billion. Elevance Health declared a fourth quarter 2024 dividend of $1.63 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.59%
Tags
Rhea-AI Summary

Elevance Health (NYSE: ELV) has announced its plans to release third quarter 2024 financial results on October 17, 2024, at 6:00 a.m. EDT. The company will host a conference call at 8:30 a.m. EDT on the same day to discuss the results and outlook. Investors can access the call using specific domestic and international numbers with an access code. A replay will be available from 11:30 a.m. EDT on October 17, 2024, until November 16, 2024. Additionally, a live webcast of the call will be accessible through the company's website under the "Investors" link, with a replay available afterwards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.01%
Tags
conferences earnings
-
Rhea-AI Summary

Elevance Health and its Elevance Health Foundation are providing $500,000 in new grant funding to support communities affected by Hurricane Helene. This funding will help community-based organizations address critical needs such as access to food, shelter, hygiene kits, and recovery supplies.

In addition to this pledge, the Foundation has preemptively provided funding to several disaster-relief organizations:

  • $1 million to the American Red Cross
  • $300,000 to Team Rubicon
  • $250,000 to Americares
  • $100,000 to Direct Relief

Elevance Health is also matching employee donations to disaster relief efforts and making it easier for members to refill prescriptions and access healthcare services during the crisis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
none
-
Rhea-AI Summary

Elevance Health (NYSE: ELV) has introduced the Whole Health Index (WHI), a groundbreaking tool for assessing individual and community health. Developed by Elevance Health's physicians, data scientists, and researchers, the WHI uses a 0-100 scale to evaluate health over time, considering physical, behavioral, and social factors.

The WHI incorporates over 90 data points across various health categories, including food insecurity, transportation accessibility, housing instability, preventative dental exams, immunizations, and mental health treatment. Elevance Health has begun providing access to WHI data for employer health plan members in Missouri and Virginia, with information available at the county level and always de-identified.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.17%
Tags
none
Rhea-AI Summary

Elevance Health, in partnership with the Impact Fitness Foundation (IFF), has provided Irvington Preparatory Academy with its first-ever weight room and fitness space. This initiative is part of Elevance Health's commitment to improving health equity and social justice. The new facility eliminates the need for staff to drive students to public fitness centers for sports and physical education training.

The transformation included converting a storage room into a state-of-the-art training facility with new equipment for functional movement. Volunteers from Elevance Health and Indiana Fever players participated in the renovation. Following the unveiling, students and coaches attended a training clinic with IFF athletic trainers and Indiana Fever players to familiarize themselves with the new facility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
none

FAQ

What is the current stock price of Elevance Health (ELV)?

The current stock price of Elevance Health (ELV) is $320 as of February 27, 2026.

What is the market cap of Elevance Health (ELV)?

The market cap of Elevance Health (ELV) is approximately 71.3B.

ELV Rankings

ELV Stock Data

71.30B
220.22M
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
INDIANAPOLIS

ELV RSS Feed